Brian Robb Douglass Repligen Corp (RGEN) insider trading activity

RGEN Quotes by TradingView

Brian Robb Douglass is CHIEF PRODUCT OFFICER of REPLIGEN CORP. Currently has a direct ownership of 8,540 shares of RGEN, which is worth approximately $1.3 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 2,288 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.54K
n/a 3M change
n/a 12M change
Total Value Held $1.3 Million

Brian Robb Douglass Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2025
BUY
Grant, award, or other acquisition
-
2,288 Added 21.13%
8,540 Common Stock
BRD

Brian Robb Douglass

CHIEF PRODUCT OFFICER
Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGEN